WebBucinnazine (AP-237, 1-butyryl-4-cinnamylpiperazine) is an opioid analgesic drug that was widely used in China to treat pain in cancer patients as of 1986. It is one of the most potent compounds among a series of piperazine-amides first synthesized and reported in Japan in the 1970s. Bucinnazine has analgesic potency comparable to that of morphine but with … WebSep 16, 2024 · The scientific knowledge regarding bucinnazine and its effects in humans is still very limited. 17, [20] [21] [22] AP-237 was classified as an NSO due to its potential …
Burzynski Movie Cancer Is Serious Business by Eric Merola
WebSep 1, 2024 · At least two metabolites of bucinnazine were identified using LC-MS/MS. Hydroxylation and dealkylation of the parent compound was observed, and an initial … Bucinnazine (AP-237, 1-butyryl-4-cinnamylpiperazine) is an opioid analgesic drug that was widely used in China to treat pain in cancer patients as of 1986. It is one of the most potent compounds among a series of piperazine-amides first synthesized and reported in Japan in the 1970s. Bucinnazine has analgesic … See more 2-methyl-AP-237 has been sold on the grey market as a designer opioid, first identified by a police forensic laboratory in Slovenia in March 2024. See more • AP-238 • Azaprocin • Diphenpipenol • MT-45 • Sunifiram See more thorsten dossow
Anyone tried actual Bucinnazine? : r/researchchemicals - Reddit
WebJul 6, 2024 · In this investigation, surface-enhanced Raman spectroscopy (SERS) technology was performed to detect bucinnazine hydrochloride (BH) injection in water … WebAs AP-237 was known as bucinnazine, the n-propionyl variants could be potentially called procinnazine with many possible shorter names. The 2-methyl-n-butaryl is often called 2MAP here. Possible … WebBucinnazine (AP-237, 1-butyryl-4-cinnamylpiperazine) is an opioid analgesic drug that was widely used in China to treat pain in cancer patients as of 1986. It is one of the most potent compounds among a series of piperazine-amides first synthesized and reported in … thorsten drews